Aldeyra Therapeutics, Inc. (ALDX)
4.59
-0.20
(-4.18%)
USD |
NASDAQ |
Dec 11, 16:00
4.58
-0.01
(-0.22%)
After-Hours: 17:56
Aldeyra Therapeutics Research and Development Expense (Quarterly): 5.431M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Vanda Pharmaceuticals, Inc. | 22.56M |
| ADMA Biologics, Inc. | 1.528M |
| Exelixis, Inc. | 199.16M |
| Anavex Life Sciences Corp. | 7.295M |